{"retracted":false,"update":{"timestamp":1410825600000,"doi":"10.1212/wnl.0000000000000853","type":"correction"},"doi":"10.1212/wnl.0000000000000594","journal":"Neurology","publisher":"Ovid Technologies (Wolters Kluwer Health)","title":"Sustained focal antitumor activity of bevacizumab in recurrent glioblastoma"}
